These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

125 related items for PubMed ID: 6191050

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Changes in immunohistochemical staining in prostatic adenocarcinoma following diethylstilbestrol therapy.
    Grignon D, Troster M.
    Prostate; 1985; 7(2):195-202. PubMed ID: 2413432
    [Abstract] [Full Text] [Related]

  • 5. [Prostatic carcinoma: immunoperoxidase study with antisera against prostatic acid phosphatase and the prostate-specific antigen].
    Mathieu MC, Caillaud JM.
    Bull Cancer; 1985; 72(5):405-13. PubMed ID: 2416371
    [Abstract] [Full Text] [Related]

  • 6. Immunohistochemical localization of prostate-specific acid phosphatase and prostate-specific antigen in stage A2 adenocarcinoma of the prostate: prognostic implications.
    Epstein JI, Eggleston JC.
    Hum Pathol; 1984 Sep; 15(9):853-9. PubMed ID: 6381284
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. The response of poorly differentiated prostatic tumors to staining for prostate specific antigen and prostatic acid phosphatase: a comparative study.
    Keillor JS, Aterman K.
    J Urol; 1987 May; 137(5):894-6. PubMed ID: 2437333
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Multiple immunoperoxidase markers in benign hyperplasia and adenocarcinoma of the prostate.
    Ellis DW, Leffers S, Davies JS, Ng AB.
    Am J Clin Pathol; 1984 Mar; 81(3):279-84. PubMed ID: 6199966
    [Abstract] [Full Text] [Related]

  • 12. Immunohistochemical demonstration of tumor-associated antigens in prostatic carcinomas of various histological differentiations.
    Friedmann W, Steffens J, Lobeck H, Blümcke S, Nagel R.
    Eur Urol; 1985 Mar; 11(1):52-6. PubMed ID: 2580711
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Prostatic-specific antigen: an immunohistologic marker for prostatic neoplasms.
    Nadji M, Tabei SZ, Castro A, Chu TM, Murphy GP, Wang MC, Morales AR.
    Cancer; 1981 Sep 01; 48(5):1229-32. PubMed ID: 6168364
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Prostate cancer-associated markers.
    Chu TM.
    Immunol Ser; 1990 Sep 01; 53():339-56. PubMed ID: 1713065
    [Abstract] [Full Text] [Related]

  • 17. [Immunohistochemical diagnosis of a case of metastatic prostate cancer to breast].
    Gotoh A, Matsuura K, Yoshimura S, Takano Y.
    Nihon Hinyokika Gakkai Zasshi; 1989 Dec 01; 80(12):1828-31. PubMed ID: 2483185
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Prospective comparison between serum monoclonal prostate specific antigen and acid phosphatase measurements in metastatic prostatic cancer.
    Ahmann FR, Schifman RB.
    J Urol; 1987 Mar 01; 137(3):431-4. PubMed ID: 2434667
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.